[{"Assets_0_FY_USD":210884000.0,"CommonStockSharesOutstanding_0_FY_shares":62862478.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-131301000.0,"NetIncomeLoss_1_FY_USD":-39969000.0,"NetIncomeLoss_4_FY_USD":-158899000.0,"StockholdersEquity_0_FY_USD":63065000.0,"Ticker":"DVAX","CIK":"1029142","name":"DYNAVAX TECHNOLOGIES CORP","OfficialName":"Dynavax Technologies Corporation Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1279198792.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190227"}]